3225 Deming Way,  Suite 140B
Middleton, WI  53562
(608) 831-9450

Keith Rowley – Principal, Accuform Technologies LLC

Keith Rowley has 29 years experience in the agrochemical and crop protection industry. For most of Mr. Rowley’s career, he worked with Monsanto in St. Louis, Missouri. During his tenure at Monsanto, he was involved in the development of chemical manufacturing processes for Roundup, Lasso, and several new Ag. Products. Mr. Rowley was also responsible for the development of EPA regulatory data for Monsanto’s new pesticide products.

Mr. Rowley joined Covance Laboratories as an Associate Director responsible for the day-to-day operations of the Agrochemical and Industrial Chemistry strategic business unit, providing contract research services to the Crop Protection industry. In 2000, Mr. Rowley joined a startup pesticide company, Ecosmart Technologies, where he directed the R&D activities toward the development of a line of agricultural products focused on the organic farming industry.

Mr. Rowley joined the Nutra-Park team in 2002 as the Director of Chemical Research and Discovery where he was responsible for laboratory operations, new AI discovery, formulation development, and manufacturing process development. Mr. Rowley holds BS degrees in Chemistry and Biology and an MS degree in Physical Organic Chemistry, from Murray State University

Thomas Richard – Principal Accuform Technologies LLC

Tom Richard obtained a PhD in synthetic organic chemistry from the Massachusetts Institute of Technology in 1978. Immediately upon leaving MIT, he began his career at Monsanto Agricultural Products Company, and rapidly rose to the position of senior research group leader. Dr. Richard's group was responsible for glyphosate® process development, and his group and he developed the “high payload” oxidative process still used for the production of glyphosate® worldwide. Tom won two Monsanto “Process Achievement Awards” for the conduct of this research. In 1986, Dr. Richard left Monsanto to pursue the field of perfluorocarbon (PFC) based biological oxygen transport agents (“blood substitutes”). Dr. Richard is the co-inventor of Oxyfluor, a PFC emulsion that has been infused in patients in two stages of clinical trials (Europe and US), without significant adverse events. With Dr. Robert F. Shaw, Dr. Richard documented the results of this work in Chapter 27, “Oxyfluor™” of the book “Blood Substitutes” (Elsevier, 2006, ed. Robert M. Winslow).

In 1996, Covance Laboratories, in Madison, Wisconsin, recruited Dr. Richard to assist in the development of an early drug development team. Subsequent to the establishment of that team, Dr. Richard returned to St. Louis as Director of Chemical Research at Chemir Laboratories. At Chemir, Dr. Richard firmly established a GLP laboratory, and grew the pharmaceutical contract business to represent a significant portion of Chemir’s revenue.

Encouraged by Dr. Shri Thanedar, the owner of Chemir Laboratories, Dr. Richard began his own consulting firm, Chemvantage Consultants, LLC, in 2001. This business takes advantage of Dr. Richard’s 28 years of experience in directing Agricultural and Pharmaceutical small molecule synthesis, process development, and deformulation to provide his clients targeted programs for efficient product development.

Chris Elliott – Principal – Accuform Technologies LLC

Chris Elliott is an executive with over 18 years experience in the agriculture, food technology and biotechnology industries. Most recently Mr. Elliott has served as President and CEO of Nutra-Park Incorporated, a biological Sciences company focused on discovery, development and commercialization of biologically active products for the agriculture industry.

Prior to his most recent appointment, Mr. Elliott served in various global Vice President roles in manufacturing, supply chain and marketing at BASF corporation.

In addition, Mr. Elliott served in multiple commercial roles at American Cyanamid including marketing, business strategy, sales and business development. Mr. Elliott holds a BS degree from the University of Illinois at Urbana Champaign, IL and an MBA from Columbia University Graduate School of Business, New York.